DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines Competitive antagonist of opioid receptors. FV naltrexone of 50 mg No. 10 (VED) *

FV naltrexone of 50 mg No. 10 (VED) *

Препарат Налтрексон ФВ 50 мг №10 (ЖНВЛС) *. ЗАО "Московская фармацевтическая фабрика" Россия


Producer: CJSC Moscow Pharmaceutical Factory Russia

Code of automatic telephone exchange: V03AB30

Release form: Firm dosage forms. Capsules.

Indications to use: Opium drug addiction. Alcoholism.


General characteristics. Structure:

Active ingredient: each capsule soderdzhit 50 mg of Naltrexone of a hydrochloride.




Pharmacological properties:

FV naltrexone competitively contacts opioid receptors of all types and warns or eliminates effect of both endogenous opioids, and exogenous morfinopodobny medicines.


Indications to use:

- treatment of opioid drug addiction for the purpose of maintenance at a sick state at which opioids will not be able to have characteristic effect (as a part of complex therapy).

Drug is appointed only after stopping of an abstinence syndrome.
- treatment of an alcoholism.


Route of administration and doses:

Use of FV Naltrexone is possible in specialized narcological departments or is out-patient under observation of the doctor.



Side effects:

At use of FV Naltrexone according to indications in therapeutic doses at patients whose organism does not contain opioids development of serious side effects was not noted.



Contraindications:

- concomitant use of opioid analgetics;
- a positive take of the analysis of urine on availability of opioids;
- lack of data on conducting provocative test with Naloxonum;
- acute gastritis; - a liver failure;
- hypersensitivity to naltrexone.




Issue conditions:

According to the recipe


Packaging:

In packaging of 10 capsules.



Similar drugs

Препарат Антаксон. ЗАО "Московская фармацевтическая фабрика" Россия

Antakson

Competitive antagonist of opioid receptors.



Препарат Налтрексон. ЗАО "Московская фармацевтическая фабрика" Россия

Naltrexone

Competitive antagonist of opioid receptors.



Препарат Налтрексон. ЗАО "Московская фармацевтическая фабрика" Россия

Naltrexone

Competitive antagonist of opioid receptors.





  • Сайт детского здоровья